Search alternatives:
significant teer » significant gender (Expand Search), significant trend (Expand Search), significant genes (Expand Search)
teer decrease » greater decrease (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
significant teer » significant gender (Expand Search), significant trend (Expand Search), significant genes (Expand Search)
teer decrease » greater decrease (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
-
201
Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index.
Published 2025“…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …”
-
202
-
203
-
204
-
205
-
206
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
207
-
208
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
209
-
210
-
211
-
212
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
213
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
214
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
215
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
216
-
217
-
218
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
219
-
220